Sci Show: Research on the ChAdOx1 nCoV-19, also known as the Oxford-AstraZeneca vaccine, indicates that a long interval between first and second doses does not compromise the immune response after a late second dose.

Tuesday, June 29, 2021

Research on the ChAdOx1 nCoV-19, also known as the Oxford-AstraZeneca vaccine, indicates that a long interval between first and second doses does not compromise the immune response after a late second dose.

https://ift.tt/35Xzznb via /r/science https://ift.tt/3y0wNJy

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)